Xultophy 100/3.6 (insulin degludec and liraglutide)

**Product type:** Human Prescription Drug

**Active ingredient:** INSULIN DEGLUDEC; LIRAGLUTIDE

**Strength:** 100; 3.6 [iU]/mL; mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Novo Nordisk

**Marketing category:** BLA (BLA208583)

**Pharmacologic class:** GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog [EPC], Insulin [CS]